Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
To discover biomarker panels that could distinguish cancers (BC and RCC) from healthy controls (HCs) and bladder cancers (BC) from renal cell carcinoma (RCC), regardless of whether the patients have haematuria. In addition, we also explored the altered metabolomic pathways of BC and RCC. | UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma